Davita Inc (DVA) Position Lifted by Dupont Capital Management Corp

Dupont Capital Management Corp lifted its stake in Davita Inc (NYSE:DVA) by 75.2% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,425 shares of the company’s stock after buying an additional 1,900 shares during the period. Dupont Capital Management Corp’s holdings in Davita were worth $240,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of DVA. CSat Investment Advisory L.P. grew its position in Davita by 61.8% during the 4th quarter. CSat Investment Advisory L.P. now owns 581 shares of the company’s stock worth $30,000 after purchasing an additional 222 shares during the last quarter. Quantamental Technologies LLC purchased a new position in Davita during the 4th quarter worth $34,000. Oregon Public Employees Retirement Fund grew its position in Davita by 4,995.1% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 1,880,451 shares of the company’s stock worth $37,000 after purchasing an additional 1,843,544 shares during the last quarter. Quadrant Capital Group LLC grew its position in Davita by 2,481.1% during the 1st quarter. Quadrant Capital Group LLC now owns 955 shares of the company’s stock worth $50,000 after purchasing an additional 918 shares during the last quarter. Finally, Fort L.P. purchased a new position in Davita during the 4th quarter worth $76,000. 90.78% of the stock is currently owned by hedge funds and other institutional investors.

Several research analysts have issued reports on DVA shares. Zacks Investment Research raised shares of Davita from a “sell” rating to a “hold” rating in a research report on Thursday, February 14th. Robert W. Baird lowered their price objective on shares of Davita from $90.00 to $70.00 and set an “outperform” rating on the stock in a research report on Friday, February 15th. They noted that the move was a valuation call. SunTrust Banks reissued a “hold” rating on shares of Davita in a research report on Wednesday, February 20th. Finally, Deutsche Bank lowered their price objective on shares of Davita from $68.00 to $66.00 and set a “buy” rating on the stock in a research report on Thursday, May 9th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and four have assigned a buy rating to the company’s stock. Davita has an average rating of “Hold” and an average target price of $67.78.

Shares of NYSE:DVA opened at $51.24 on Wednesday. The stock has a market capitalization of $8.52 billion, a PE ratio of 14.35, a PEG ratio of 0.54 and a beta of 1.28. The company has a current ratio of 1.12, a quick ratio of 1.11 and a debt-to-equity ratio of 2.06. Davita Inc has a fifty-two week low of $48.25 and a fifty-two week high of $79.11.

Davita (NYSE:DVA) last issued its earnings results on Tuesday, May 7th. The company reported $0.91 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.95 by ($0.04). The firm had revenue of $2.74 billion during the quarter, compared to analysts’ expectations of $2.82 billion. Davita had a net margin of 1.15% and a return on equity of 13.96%. The firm’s revenue was down 3.7% on a year-over-year basis. During the same period in the previous year, the firm earned $1.05 EPS. On average, equities analysts predict that Davita Inc will post 4.26 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This report was originally posted by Baseball Daily News and is owned by of Baseball Daily News. If you are viewing this report on another site, it was illegally copied and republished in violation of United States and international copyright and trademark laws. The original version of this report can be viewed at https://www.baseballdailydigest.com/news/2019/05/15/davita-inc-dva-position-lifted-by-dupont-capital-management-corp.html.

Davita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

Featured Story: What are the qualifications of a portfolio manager?

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Davita Inc (NYSE:DVA).

Institutional Ownership by Quarter for Davita (NYSE:DVA)

Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.